Avenue Therapeutics ATXI
OTC ATXI
$0.40 +0.00 (+0.00%)
At close: Oct 21, 2026 · 4:00 PM EDT

Avenue Therapeutics (ATXI) EBT Margin (2025)

Updated

Avenue Therapeutics (ATXI) posted EBT Margin of -210.97% for FY2025.

Analysis

Avenue Therapeutics (ATXI) EBT Margin (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn 0.13%
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 25.18%
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 29.63%
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 18.19%
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn 27.53%
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -131.41%
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn -4.34%
10 Avenue Therapeutics 1.32 Mn -9.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 23.36%
API Access

Avenue Therapeutics EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=ATXI&period=max&api_key=YOUR_API_KEY